Acute encephalopathy coincident with seroconversion for anti-HTLV-III.

PubWeight™: 2.26‹?› | Rank: Top 2%

🔗 View Article (PMID 2866290)

Published in Lancet on November 30, 1985

Authors

C A Carne, R S Tedder, A Smith, S Sutherland, S G Elkington, H M Daly, F E Preston, J Craske

Articles citing this

Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J Virol (2008) 5.24

Acute meningoencephalitis and meningitis due to primary HIV infection. BMJ (2002) 2.52

Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. BMJ (1988) 1.75

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis (2011) 1.59

Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol (1989) 1.49

Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol (1991) 1.42

Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate. J Virol (2001) 1.31

Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J Virol (1998) 1.30

Severe illness associated with appearance of antibody to human immunodeficiency virus in an African. Br Med J (Clin Res Ed) (1986) 1.27

Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees. Proc Natl Acad Sci U S A (1987) 1.09

Pandemic (H1N1) 2009 and HIV co-infection. Emerg Infect Dis (2010) 1.09

Neurological manifestations of human immunodeficiency virus infection. Br Med J (Clin Res Ed) (1986) 0.99

Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study. J Neurol Neurosurg Psychiatry (1998) 0.96

Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev (1993) 0.94

Anti-HIV antibodies in the CSF of AIDS patients: a serological and immunoblotting study. J Neurol Neurosurg Psychiatry (1988) 0.86

Subclinical neurological and neuropsychological effect of infection with HIV. Genitourin Med (1989) 0.84

Serial MRI of the brain in asymptomatic patients infected with HIV: results from the UCMSM/Medical Research Council neurology cohort. J Neurol Neurosurg Psychiatry (1994) 0.81

Clinical, virological and immunological features of primary HIV-1 infection. Genitourin Med (1991) 0.80

Acute transient inflammatory leukoencephalopathy in HIV. Neurol Sci (2011) 0.80

Neurologic signs and symptoms frequently manifest in acute HIV infection. Neurology (2016) 0.80

Subacute encephalopathy associated with human immunodeficiency virus in haemophilia A. Br Med J (Clin Res Ed) (1986) 0.80

Coma as a presenting symptom of primary HIV infection. Sex Transm Infect (2007) 0.79

Analysis of metabolic changes of brain in HIV-1 seropositive patients with proton magnetic resonance spectroscopy. Pol J Radiol (2010) 0.78

Influenza-like syndrome in homosexual men: a prospective diagnostic study. J R Coll Gen Pract (1988) 0.78

Acute infection with human immunodeficiency virus presenting with neurogenic urinary retention. Genitourin Med (1991) 0.78

Neurology of AIDS virus infection: a clinical classification. Yale J Biol Med (1988) 0.75

Recent advances in the neurology of HIV infection. Postgrad Med J (1994) 0.75

Human immunodeficiency virus (HIV) infection for the general physician. Postgrad Med J (1987) 0.75

Atrial natriuretic peptides: clues to their physiological and clinical importance. Postgrad Med J (1987) 0.75

Articles by these authors

Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell (1998) 19.05

Explaining variation in general practitioner referrals to hospital. Fam Pract (1987) 10.27

Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev (1998) 8.51

Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (1985) 6.65

Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20

Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet (2000) 5.93

Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet (1984) 5.20

Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet (1985) 4.99

Assessing completeness of cancer registration in the north-western region of England by a method of independent comparison. Br J Cancer (1982) 4.90

14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet (1999) 4.80

Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst (1981) 4.60

Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn (2010) 4.48

Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci U S A (1994) 4.44

Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet (1998) 4.44

The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci (1999) 4.35

Smoking habits of oral contraceptive users. Lancet (1969) 4.20

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05

Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet (1990) 4.01

Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol (1999) 4.00

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med (2001) 3.98

Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet (1992) 3.94

Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science (1999) 3.85

Factor VIII gene rearrangements in patients with severe haemophilia A. Lancet (1994) 3.56

Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut (1985) 3.48

Identification of the NH2-terminal blocking group of calcineurin B as myristic acid. FEBS Lett (1982) 3.42

Antibody capture radioimmunoassay for anti-rubella IgM. J Hyg (Lond) (1981) 3.38

Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol (1993) 3.36

Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves. J Epidemiol Community Health (1980) 2.95

A novel lymphotropic herpesvirus. Lancet (1987) 2.89

Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS (1997) 2.88

Caesarean scar pregnancy. BJOG (2007) 2.77

The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. BMJ (2009) 2.74

Predicting successful vaginal birth after Cesarean section using a model based on Cesarean scar features examined by transvaginal sonography. Ultrasound Obstet Gynecol (2013) 2.73

Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London. Lancet (1985) 2.72

Genital Chlamydia trachomatis infections in primary care. BMJ (1996) 2.71

Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group. Br J Cancer (1995) 2.71

Audit commission tackles anaesthetic services. BMJ (1998) 2.70

Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol (2007) 2.69

Delay in breast cancer and the nature of presenting symptoms. Lancet (1981) 2.67

A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54

Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J (2003) 2.51

The effect of adjunctive fresh frozen plasma administration on coagulation parameters and survival in a canine model of antivenom-treated brown snake envenoming. Anaesth Intensive Care (2005) 2.49

Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic. BMJ (1991) 2.49

Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47

Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br Med J (Clin Res Ed) (1986) 2.47

A national health service and the public health. Public Health (1988) 2.46

Intravenous acyclovir treatment for primary genital herpes. Lancet (1982) 2.45

Hepatitis C antibody and chronic liver disease in haemophilia. Lancet (1990) 2.44

On-site HIV testing in resource-poor settings: is one rapid test enough? AIDS (1997) 2.39

Randomised controlled trial of self management leaflets and booklets for minor illness provided by post. BMJ (2001) 2.35

Cerebral intravascular coagulation in diabetic ketoacidosis. Lancet (1974) 2.35

Microchimerism of maternal origin persists into adult life. J Clin Invest (1999) 2.35

Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol (2002) 2.34

Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34

Antimicrobial resistance: Antibiotics and consultant oral microbiologist posts. Br Dent J (2016) 2.32

Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis (2003) 2.29

Clinical pharmacology clinics in general practice. Br Med J (1977) 2.28

Qualms about QALYs. Lancet (1987) 2.26

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol (2001) 2.24

Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol (1992) 2.22

Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS (1997) 2.20

Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol (1998) 2.20

Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation. Thromb Haemost (1998) 2.20

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet (1997) 2.19

Increased incidence of cervical cytological abnormalities in women with genital warts or contact with genital warts: a need for increased vigilance? Genitourin Med (1991) 2.19

Essential thrombocythaemia and peripheral gangrene. Br Med J (1974) 2.18

Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol (1981) 2.16

The UK blood transfusion service: over a (patent) barrel? Lancet (2002) 2.15

Human herpesvirus 6 in salivary glands. Lancet (1990) 2.15

Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability. Thromb Haemost (1999) 2.15

Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch Gen Psychiatry (1997) 2.15

A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine. J Med Virol (1992) 2.15

Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein. J Cell Biol (1983) 2.14

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost (2005) 2.13

A quantitative assessment of residual protein levels on dental instruments reprocessed by manual, ultrasonic and automated cleaning methods. Br Dent J (2011) 2.13

Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance. Intern Med J (2001) 2.12

Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet (1990) 2.11

Birthing pools and infection control. Lancet (1996) 2.09

Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08

Cross infection control measures and the treatment of patients at risk of Creutzfeldt Jakob disease in UK general dental practice. Br Dent J (2001) 2.08

Outcome of elective prostatectomy. BMJ (1989) 2.08

The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab (1995) 2.07

Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. BMJ (1993) 2.07

Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech Dev (1994) 2.07

Sequence of the preprotoxin dsRNA gene of type I killer yeast: multiple processing events produce a two-component toxin. Cell (1984) 2.03

A verandah-trap hut for studying the house-frequenting habits of mosquitoes and for assessing insecticides. 3. The effect of DDT on behavior and mortality. Bull Entomol Res (1969) 2.03

The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM. J Hyg (Lond) (1982) 2.02

The management of acute abdominal pain in children. J Paediatr Child Health (1996) 2.02

Prophylactic oral acyclovir in recurrent genital herpes. Lancet (1984) 1.99

Does the presence of a cesarean section scar influence the site of placental implantation and subsequent migration in future pregnancies: a prospective case-control study. Ultrasound Obstet Gynecol (2012) 1.98

Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res (1996) 1.95

The cardiac conduction system in situs ambiguus. Circulation (1979) 1.92

"Multidimensionally impaired disorder": is it a variant of very early-onset schizophrenia? J Am Acad Child Adolesc Psychiatry (1998) 1.90

Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother (1998) 1.89

Human immunodeficiency viruses in patients attending a sexually transmitted disease clinic in London, 1982-7. BMJ (1989) 1.89